Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB VENUS REMEDIES DR. REDDYS LAB/
VENUS REMEDIES
 
P/E (TTM) x 19.7 15.0 131.1% View Chart
P/BV x 4.4 0.9 468.2% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 DR. REDDYS LAB   VENUS REMEDIES
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
VENUS REMEDIES
Mar-23
DR. REDDYS LAB/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs4,656379 1,228.8%   
Low Rs3,788145 2,612.1%   
Sales per share (Unadj.) Rs1,481.4415.5 356.5%  
Earnings per share (Unadj.) Rs270.719.9 1,362.2%  
Cash flow per share (Unadj.) Rs345.744.0 785.3%  
Dividends per share (Unadj.) Rs40.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs1,389.6344.3 403.6%  
Shares outstanding (eoy) m166.5313.37 1,245.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.80.6 452.1%   
Avg P/E ratio x15.613.2 118.3%  
P/CF ratio (eoy) x12.25.9 205.3%  
Price / Book Value ratio x3.00.8 399.4%  
Dividend payout %14.80-   
Avg Mkt Cap Rs m703,0393,501 20,078.3%   
No. of employees `000NANA-   
Total wages/salary Rs m46,466570 8,145.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,6975,555 4,440.9%  
Other income Rs m10,555103 10,225.7%   
Total revenues Rs m257,2525,658 4,546.4%   
Gross profit Rs m63,860602 10,607.8%  
Depreciation Rs m12,502323 3,870.8%   
Interest Rs m1,4283 48,571.4%   
Profit before tax Rs m60,485379 15,946.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,412114 13,560.9%   
Profit after tax Rs m45,073266 16,966.4%  
Gross profit margin %25.910.8 238.9%  
Effective tax rate %25.530.0 85.0%   
Net profit margin %18.34.8 382.1%  
BALANCE SHEET DATA
Current assets Rs m203,1613,230 6,290.7%   
Current liabilities Rs m85,721826 10,381.6%   
Net working cap to sales %47.643.3 110.0%  
Current ratio x2.43.9 60.6%  
Inventory Days Days7937 214.6%  
Debtors Days Days107504 21.3%  
Net fixed assets Rs m112,6382,781 4,049.9%   
Share capital Rs m833134 623.2%   
"Free" reserves Rs m230,5714,470 5,158.5%   
Net worth Rs m231,4044,603 5,026.8%   
Long term debt Rs m1,278387 330.4%   
Total assets Rs m315,7996,011 5,253.9%  
Interest coverage x43.4130.0 33.3%   
Debt to equity ratio x00.1 6.6%  
Sales to assets ratio x0.80.9 84.5%   
Return on assets %14.74.5 329.5%  
Return on equity %19.55.8 337.5%  
Return on capital %26.67.7 347.4%  
Exports to sales %52.20-   
Imports to sales %16.80-   
Exports (fob) Rs m128,803NA-   
Imports (cif) Rs m41,484NA-   
Fx inflow Rs m128,8030-   
Fx outflow Rs m41,4840-   
Net fx Rs m87,3190-   
CASH FLOW
From Operations Rs m58,875366 16,074.2%  
From Investments Rs m-41,373-508 8,139.5%  
From Financial Activity Rs m-26,861-6 472,904.9%  
Net Cashflow Rs m-9,073-220 4,115.9%  

Share Holding

Indian Promoters % 26.7 41.8 63.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 47.3 1.6 2,973.0%  
FIIs % 28.6 1.6 1,800.0%  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 58.2 99.6%  
Shareholders   257,794 19,560 1,318.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs VENUS REMEDIES Share Price Performance

Period Dr. Reddys VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 1.78% 7.05% 1.18%
1-Month -4.23% -4.10% -0.75%
1-Year 35.93% 103.11% 61.82%
3-Year CAGR 10.85% 4.62% 18.16%
5-Year CAGR 17.77% 58.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.